Published in
American Society for Clinical Pharmacology and Therapeutics, Clinical Pharmacology & Therapeutics, 2(102), p. 313-320
DOI: 10.1002/cpt.617
Links
Tools
A Pharmacokinetic and Safety Study of Trebananib, an Fc-Fusion Peptibody, in Patients With Advanced Solid Tumors and Varying Degrees of Renal Dysfunction
Journal article published in 2017 by
B. Wu,
Ld Lewis,
Rd Harvey 
,
E. Rasmussen,
E. Gamelin,
Y.-N. Sun,
G. Friberg,
Jl Koyner,
A. Dowlati,
Ml Maitland
,
E. Rasmussen,
E. Gamelin,
Y.-N. Sun,
G. Friberg,
Jl Koyner,
A. Dowlati,
Ml Maitland
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 